At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 40 enrolled
Drug / intervention
Fish oil +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Omega-3 Fatty Acids From Fish Oil on the Gene Expression in Healthy Humans and Humans With Hypertriglyceridemia
Gottfried Wilhelm Leibniz Universität Hannover·interventional·Posted Mar 18, 2010·Updated Dec 19, 2011
In Brief
A Phase 4 clinical trial evaluating Fish oil and Placebo (corn oil) for Hyperlipidemia and Healthy. Completed, enrolled 40 participants across 1 site.
Detailed Summary
The aim of this study is to investigate the effects of short- and long-term intervention with EPA and DHA-rich fish oil on gene expression profiles in healthy and hyperlipidemic males.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperlipidemia, Healthy
CountriesGermany
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2010
First PostedMar 2010
Primary CompletionJul 2010
Study CompletionJul 2011
TodayJul 2026
First PostedMar 18, 2010
Enrollment StartMar 1, 2010
Primary CompletionJul 1, 2010
Study CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 16.3 years ago
Interventions
Fish oildietary
Dietary Supplement: fish oil capsules (6 per day) 3024 mg n-3 fatty acids daily (1512 mg EPA and 1008 mg DHA) about 3 months
Placebo (corn oil)dietary
corn oil (6 capsules per day)